SCHEMBL7984948

SCHEMBL7984948

O=c1[nH]c(-c2ccc(O)c(O)c2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.55
ALDH1A1 P00352 3/20 0.55
HPGD P15428 1/20 0.53
KMT2A Q03164 1/20 0.52
GUSB P08236 4/20 0.51
CNOT7 Q9UIV1 2/20 0.43
PARN O95453 1/20 0.43
PNP P00491 2/20 0.41
GAA P10253 1/20 0.40
BRD4 O60885 1/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988556 0.88 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7985332 0.87 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7988785 0.87 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7975265 0.86 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7975129 0.84 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7984453 0.84 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7984883 0.84 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7974010 0.83 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7984655 0.83 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7974505 0.83 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed